Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)-Reference-Cited by-同舟云学术

Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)

Published:2016-07 Issue: Volume:177 Page:58-65
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Ren Shu,Hure Alexis,Peel Roseanne,D'Este Catherine,Abhayaratna Walter,Tonkin Andrew,Hopper Ingrid,Thrift Amanda G.,Levi Christopher,Sturm Jonathan,Durrheim David,Hung Joseph,Briffa Thomas,Chew Derek P.,Anderson Phil,Moon Lynelle,McEvoy Mark,Hansbro Philip,Newby David,Attia John

Funder

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. The atlas of heart disease and stroke;Mackay,2004

2. Immunity, atherosclerosis and cardiovascular disease;Frostegard;BMC Med,2013

3. Relationship between the sialic acid content of low-density lipoprotein (LDL) and autoantibodies to oxidized LDL in the plasma of healthy subjects and patients with atherosclerosis;Cerne;Clin Chem Lab Med,2002

4. Immunization of LDL receptor–deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes;Freigang;Arterioscler Thromb Vasc Biol,1998

5. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis;Karvonen;Circulation,2003

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherosclerosis antigens as targets for immunotherapy;Nature Cardiovascular Research;2023-12-11

2. Persistence of Detectable Anti-Pneumococcal Antibodies 4 Years After Pneumococcal Polysaccharide Vaccination in a Randomised Controlled Trial: The Australian Study for the Prevention through Immunisation of Cardiovascular Events (AUSPICE);Heart, Lung and Circulation;2023-11

3. The role of pneumococcal vaccination in reducing cardiovascular risk in cardiac patients: Expert opinion of the Prevention Committee of the Polish Cardiac Society supported by the Polish Vaccinology Society;Kardiologia Polska;2023-10-31

4. Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future;International Journal of Molecular Sciences;2023-07-01

5. Effect of Pneumococcal Vaccine on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-06-30